MDSCs inhibit cytotoxic responses mediated by natural killer cells, and block the activation of tumor-reactive CD4 + T helper (CD4 + Th) cells and CD8 + T cytotoxic (CD8 + Tc) cells12,20. This evidence concerns the gene CD4 and neoplasm.